< Back to companies

Nazata Bio is a healthcare startup focused on developing digital therapeutics aimed at managing high blood pressure, a leading risk factor for all-cause mortality worldwide. The company's flagship product, the HeartShield app, empowers patients to reduce their blood pressure through personalized guidance. The app utilizes a personalization algorithm to tailor treatment to each patient's unique needs, ensuring optimal outcomes. Patients receive support from a team of specialists, including dietitians, exercise coaches, and behavioral scientists, facilitating comprehensive management of their condition. This innovative approach aims to achieve the greatest reduction in blood pressure, which is crucial in preventing serious health events such as heart attacks, strokes, and heart failure.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2021
Website
www.nazatabio.com/

Categories

Digital TherapeuticsCardiovascular DiseasePreventionTherapeutics

Disease Areas

Technologies

Digital Therapeutics
Only accessible to MedStartr community members. Join now

What do you think of Nazata Bio?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now